Premium IOLs in Imperfect Eyes

Dr. Kavitha Sivaraman and Dr. Dagny Zhu discuss premium options for patients with corneal pathology and post-refractive corneas.

Ophthalmology Management April 12, 2026 Vol 30, Issue ASCRS 2026

Clinical Report: Premium IOLs in Imperfect Eyes

Overview

Revise to include specific corneal conditions and their impact on lens selection.

Background

The use of premium IOLs in patients with corneal irregularities presents unique challenges and opportunities. As advancements in lens technology continue, it is crucial for surgeons to understand when these lenses can be safely and effectively utilized. This topic is particularly relevant given the increasing number of patients with prior refractive surgeries seeking cataract treatment.

Data Highlights

No numerical data was provided in the source material.

Key Findings

Premium IOLs can be considered in eyes with corneal pathology, provided patient expectations are managed.
Post-refractive surgery patients may still benefit from premium IOLs, contrary to previous beliefs.
Understanding the type of corneal irregularity is essential for selecting the appropriate IOL.
Reproducible measurements are critical in determining the suitability of premium IOLs.
Small-aperture optics may be a viable option for patients with aberrated eyes.

Clinical Implications

Surgeons should evaluate each patient's corneal condition and expectations when considering premium IOLs. Utilizing modern biometry techniques and understanding the implications of corneal irregularities can enhance surgical outcomes.

Conclusion

The selection of premium IOLs in patients with imperfect corneas requires careful consideration of individual circumstances and advancements in technology. Ongoing education and adaptation of practices are essential for optimizing patient care.

PentaVision

Ophthalmology Management